About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« New Frontiers in Self-Deception | Main | Ariad's Day in Court »

April 10, 2006


Email This Entry

Posted by Derek

I have Schedule D to wrestle with tonight, so it's time for some linking and blogroll additions. I'll start with a relatively new blog from a pharma consultant, Eye on FDA, and that'll do it from the industrial side this time.

The rest are from academia, some pure chemistry sites such as Dylan Stiles', which I've already linked to. I enjoy his site a lot, but one thing that it tells me is something that I already knew - namely, that I'm not 25 any more. Another blogging chem grad student is Paul Bracher, at Harvard. Another site for hard-core organic chemistry fans is Totally Synthetic. I did just this sort of thing for my PhD, and it's a lot more fun to read about than it is to do. Another blog from inside academia, this time from a post-doc, is Interfacial Science. Another post-doc can be found at Post Doc Ergo Propter Doc.

I can also recommend Nature's venture into chem-blogging, the group-written Sceptical Chymist. (That's the name I put on my first notebook in my first-year Quantitative Analysis course, actually - Robert Boyle is definitely worth remembering).

And finally, there's Peter Rost, famously ex-Pfizer. You're unlikely to find very many points of agreement between his worldview and mine, but you can see for yourself here.

Comments (6) + TrackBacks (0) | Category: Blog Housekeeping


1. shrinkette on April 10, 2006 9:15 PM writes...

Good luck with Schedule D. This year, for the first time in my life, I had to pay Alternative Minimum Tax. :^(

Permalink to Comment

2. Derek Lowe on April 10, 2006 10:09 PM writes...

We missed the AMT by a hair this year - each year the damn thing gets closer, and I'm afraid that next year we may succumb.

My Schedule D is a bit lively, but it's nothing compared to the 2000 and 2001 returns, which were downright Proustian in length and complexity. . .

Permalink to Comment

3. tom bartlett on April 11, 2006 8:40 AM writes...

So, how'd you do? Did your extensive knowledge of The Business lead you to profit or loss?

Permalink to Comment

4. Derek Lowe on April 11, 2006 9:38 AM writes...

Y'know, that's a blog post in itself. But the short version is no, over the last few years I've had the usual mix of winners and losers. And my biggest losers, almost without exception, have been my attempts to apply my knowledge of pharma and biotech to small companies with growth potential.

There are two ways to interpret these results. . .

Permalink to Comment

5. tom bartlett on April 11, 2006 9:59 AM writes...

"There are two ways to interpret these results. . ."

I understand. Heck, I hold some ELN.

Permalink to Comment

6. Milo on April 11, 2006 12:23 PM writes...

So can we expect witty critiques of Rost's posts?

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry